Novoprotein Scientific Inc. (SHA:688137)

Novoprotein Scientific Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	138.6	127.4	153.05	264.33	341.79	179.73
Other Revenue	1.39	0.15	0.14	0.22	0.11	0.11
Revenue	139.99	127.56	153.19	264.55	341.9	179.84
Revenue Growth (YoY)	1.33%	-16.73%	-42.09%	-22.62%	90.11%	399.79%
Cost of Revenue	80.92	73.47	70.69	54.3	54.55	25.01
Gross Profit	59.07	54.08	82.5	210.25	287.35	154.83
Selling, General & Admin	101.4	101.09	87.84	82.94	69.29	39.93
Research & Development	53.61	49.92	44.79	41.1	34.1	14.97
Other Operating Expenses	16.54	1.29	0.67	3.01	3.9	2.86
Operating Expenses	169.94	154.39	131.72	128.27	111.17	58.79
Operating Income	-110.87	-100.31	-49.22	81.98	176.17	96.04
Interest Expense	-3.07	-3.59	-3.59	-4.05	-1.8	-1
Interest & Investment Income	36.54	41.48	49.42	9.07	2.39	0.17
Currency Exchange Gain (Loss)	0.15	0.71	0.65	2.84	-0.81	-2.18
Other Non Operating Income (Expenses)	0.13	-0.43	-0.49	-0.16	-0.18	-0.04
EBT Excluding Unusual Items	-77.1	-62.14	-3.23	89.69	175.77	92.99
Gain (Loss) on Sale of Investments	-	-1.8	-1.75	3.55	-0.14	0.14
Gain (Loss) on Sale of Assets	0.79	0.05	-0.09	-0.04	0.03	-
Asset Writedown	-6.61	-6.61	-	-	-0.15	-0.04
Other Unusual Items	16.27	16.29	11.29	12.98	0.72	1.06
Pretax Income	-66.66	-54.22	6.22	106.18	176.23	94.15
Income Tax Expense	3.08	0.2	-6.62	15.46	27.22	11.1
Net Income	-69.73	-54.42	12.84	90.72	149.01	83.05
Net Income to Common	-69.73	-54.42	12.84	90.72	149.01	83.05
Net Income Growth	-	-	-85.84%	-39.12%	79.42%	-
Shares Outstanding (Basic)	70	70	71	57	40	16
Shares Outstanding (Diluted)	70	70	71	57	40	16
Shares Change (YoY)	-1.62%	-2.23%	25.05%	42.83%	151.52%	-
EPS (Basic)	-0.99	-0.78	0.18	1.59	3.73	5.23
EPS (Diluted)	-0.99	-0.78	0.18	1.59	3.73	5.23
EPS Growth	-	-	-88.68%	-57.37%	-28.67%	-
Free Cash Flow	-80.26	-31.57	24.22	-33.39	1.02	85.76
Free Cash Flow Per Share	-1.15	-0.45	0.34	-0.58	0.03	5.40
Dividend Per Share	-	-	0.500	0.500	-	-
Gross Margin	42.20%	42.40%	53.85%	79.47%	84.05%	86.09%
Operating Margin	-79.20%	-78.64%	-32.13%	30.99%	51.53%	53.41%
Profit Margin	-49.81%	-42.66%	8.38%	34.29%	43.58%	46.18%
Free Cash Flow Margin	-57.33%	-24.75%	15.81%	-12.62%	0.30%	47.69%
EBITDA	-98	-88.48	-39.11	90.5	180.01	97.71
EBITDA Margin	-70.00%	-69.37%	-25.53%	34.21%	52.65%	54.33%
D&A For EBITDA	12.87	11.83	10.11	8.52	3.83	1.67
EBIT	-110.87	-100.31	-49.22	81.98	176.17	96.04
EBIT Margin	-79.20%	-78.64%	-32.13%	30.99%	51.53%	53.41%
Effective Tax Rate	-	-	-	14.56%	15.45%	11.79%
Revenue as Reported	139.99	127.56	153.19	264.55	341.9	179.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.